StonvexLoading…
StonvexStonvexStonvexCore line items from IMXI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $121.95M | $607.78M | $460.36M | $305.44M |
Operating Income | $3.67M | $55.65M | $44.07M | $33.54M |
Net Income | $511.00K | $32.67M | $23.74M | $18.78M |
EPS (Diluted) | $0.02 | $1.08 | $0.79 | $0.62 |
Total Assets | $565.94M | $517.69M | $478.73M | $518.01M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $170.32M | $168.68M | $151.59M | $174.72M |
Free Cash Flow OCF − CapEx | $-42.86M | $15.81M | $35.80M | $71.34M |
Shares Outstanding | 30.12M | 29.72M | 29.71M | 29.42M |